Traditional cold chain temperature monitoring relies heavily on validated routes along with tested processes to insure that drugs and biologics are delivered in the expected condition. But traditional approaches have several flaws.
This article by industry consultant Peter Norton reviews current cold chain processes and examines how in-transit temperature monitoring provides advantages over traditional cold chain models.
Please fill out the form and click submit to receive a copy of the article.
